This is a challenging time to be a patient or a patient advocate. Extensive cuts at NIH and FDA, a retraction of DEI commitments, major universities losing their funding—all threaten…
Over the past couple of weeks, the media was filled with articles and clips of actor Colin Farrell. He wasn’t promoting a new movie this time, but bringing his considerable…
Last week, Adam Feuerstein of STAT+ posted a news story that underscored the complexity of relationships between patient organizations and pharmaceutical companies. See story here. According to STAT, the…
As partners dedicated to advancing diversity and inclusivity in clinical trials, Pyxis Partners and Rx4good welcome the recently released U.S. Food and Drug Administration (FDA) draft guidance on diversity action plan requirements for…
Diversity action plan requirements, when finalized by FDA, will improve inclusion of communities historically underrepresented in medical research. Washington, DC (March 5, 2024) – Recently members of the Congressional Committee…
Topline findings from a survey of more than 600 caregivers now available for download.
Learn More